m+Medelevator.RU
← Поиск публикаций
Bioengineering (Basel, Switzerland) · 2026

Optimization of a 3D Skin Equivalent Incorporating Melanocytes or Melanoma Cells for In Vitro Melanoma Research.

СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Hasterok Sylwia, Jankovskaja Skaidre, Prgomet Zdenka, Ohlsson Lars, Gustafsson Anna

Аннотация

Replicating the complex physiology of human skin in vitro remains a challenge for cutaneous oncology. Although several three-dimensional (3D) skin and melanoma models have been developed, reproducible skin equivalent systems that enable direct and standardized comparisons between healthy and melanoma-containing skin remain valuable experimental tools. This study aimed to optimize and characterize skin equivalents containing either melanocytes or melanoma cells and to evaluate their utility as platforms for investigating melanoma-associated skin biology and UVB-induced responses in vitro. To achieve this, 3D skin equivalents containing fibroblasts, keratinocytes, and either melanocytes or melanoma cells were reconstructed on a polystyrene scaffold to generate healthy (mc) and melanoma (mm) models. Morphological characteristics were compared with clinically verified human tissue sections, and functional responses to UVB irradiation were assessed with a focus on the kynurenine pathway. The models demonstrated a distinct dermal-epidermal architecture and distinguishable melanoma-associated features, including epidermis-confined melanoma cell clusters, in mm constructs. UVB exposure induced differential responses between models, including significant differences in kynurenine pathway regulation. These findings suggest that the developed skin equivalents provide a reproducible in vitro platform for studying melanoma-associated skin biology and treatment-related metabolic responses and may support future mechanistic studies of skin cancer progression.

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты